☆ 4.1 Article

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials

Journal of Managed Care & Specialty Pharmacy (2020)

Get Full Text
Add to Collection

Journal

Journal of Managed Care & Specialty Pharmacy
Volume 26, Issue 7, Pages 888-900

Publisher

Academy of Managed Care Pharmacy
DOI: 10.18553/jmcp.2020.26.7.888

Keywords

-

Categories

Health Care Sciences & Services

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.